gabapentin
NDC 70771-1861, gabapentin, tablet, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1861
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203934
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1861 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1861-2 | 70771186102 | 10 TABLET in 1 BLISTER PACK (70771-1861-2) |
| 70771-1861-5 | 70771186105 | 500 TABLET in 1 BOTTLE (70771-1861-5) |
| 70771-1861-9 | 70771186109 | 90 TABLET in 1 BOTTLE (70771-1861-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8c0eeefc-ef5b-49f4-8411-ddbae312ed05
Use it
Look up 70771-1861 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1861 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1861. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.